Assess whether related-party sales should be backed out of valuation (7fa7c9)

SITUATION A family-office reviewing a manufacturing target cannot treat a TSA that expires before replacement systems exist as incidental context on QoE add-backs the seller marked 'normalized'. Customer-contract risk reviewer must close related-party sales should be from that extract under M&A Due Diligence / Legal, IP, and Regulatory.

DECISION Customer-contract risk reviewer in a family-office reviewing a manufacturing target must choose Proceed / Reprice / Walk / Hold using QoE add-backs the seller marked 'normalized' after a TSA that expires before replacement systems exist.

HYPOTHESES TO TEST 1. Customer-contract risk reviewer can defend Proceed from QoE add-backs the seller marked 'normalized' after a TSA that expires before replacement systems exist in a M&A Due Diligence challenge. 2. Customer-contract risk reviewer cannot defend Proceed from QoE add-backs the seller marked 'normalized'; Reprice is what the extract actually supports after a TSA that expires before replacement systems exist. 3. A TSA that expires before replacement systems exist never reached the population in QoE add-backs the seller marked 'normalized' — reopen intake, do not close related-party sales should be. 4. Two facts in QoE add-backs the seller marked 'normalized' after a TSA that expires before replacement systems exist conflict for customer-contract risk reviewer; hold this Legal, IP, and Regulatory file.

ANALYSIS REQUIRED 1. Separate a one-off add-back from a recurring earnings issue in QoE add-backs the seller marked 'normalized'. 2. Map reps, earnout mechanics, and integration risk a family-office reviewing a manufacturing target would inherit. 3. Tie quality-of-earnings, working-capital, and contingent items in QoE add-backs the seller marked 'normalized' to related-party sales should be. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read QoE add-backs the seller marked 'normalized' against a TSA that expires before replacement systems exist and write the one fact that would move related-party sales should be for customer-contract risk reviewer.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (QoE add-backs the seller marked 'normalized' after a TSA that expires before replacement systems exist). Lead with the M&A Due Diligence option QoE add-backs the seller marked 'normalized' can support after a TSA that expires before replacement systems exist, then the two facts that force it, then the Monday action for customer-contract risk reviewer in a family-office reviewing a manufacturing target.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on related-party sales should be, then the evidence in QoE add-backs the seller marked 'normalized', then the action for customer-contract risk reviewer - Hypothesis scorecard against QoE add-backs the seller marked 'normalized': supported / rejected / untestable - Owner and next date for customer-contract risk reviewer in a family-office reviewing a manufacturing target - What changes related-party sales should be if a TSA that expires before replacement systems exist is later withdrawn